Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...

“Milacron is an iconic American manufacturing business with a 50-year legacy of driving innovation in plastics,” said Matt Evans, a partner at Bain Capital Special Situations in a statement.

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...

Founded in 1678, Tanabe Pharma is headquartered in Doshomachi, Osaka Bain Capital has made over 37 investments in Japan since establishing its Tokyo office in 2006 The transaction is expected to ...

Bain Capital is making its latest biotech bid in Japan, where it plans to acquire Mitsubishi Tanabe Pharma Corp. The Boston-based private investment firm is buying Tanabe Pharma from Mitsubishi ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It is a new position. Largay oversees the team’s debt and financing ...

US PRIVATE equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after rival suitor KKR raised its offer above Bain’s in a protracted bidding war.

Batesville, Ind.-based Hillenbrand Inc. is selling the majority of its Milacron injection molding and extrusion business to an affiliate of Bain Capital for $287 million. The sale of 51 percent of ...

Australia-based startup Index, which makes a planning tool for product managers and software engineering teams, recently raised over $2 million in seed funding. Bain Capital Ventures and Blackbird ...

Batesville, Ind.-based Hillenbrand is selling the majority of its Milacron injection molding and extrusion business to an affiliate of Bain Capital for $287 million. The sale of 51 percent of the ...